6 FDA actions
ENSPRYNG (SATRALIZUMAB)
GENENTECH
PERJETA (PERTUZUMAB)
KADCYLA (ADO-TRASTUZUMAB EMTANSINE)
POLIVY (POLATUZUMAB VEDOTIN)
GAZYVA (OBINUTUZUMAB)
ACTEMRA (TOCILIZUMAB)